Clinical Evidence: How Saxenda vs Wegovy Compare
Saxenda vs Wegovy: Clinical Trial Weight Loss Results
When comparing Saxenda vs Wegovy results, the clinical evidence reveals important differences in weight management outcomes. In the landmark STEP 1 trial, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). Meanwhile, Saxenda's SCALE trials demonstrated around 8% average weight loss over 56 weeks when combined with lifestyle interventions.
These results reflect different trial designs and patient populations, making direct comparisons complex. Both treatments work as GLP-1 receptor agonists but with distinct dosing schedules — Wegovy requires weekly injections while Saxenda needs daily administration. The convenience factor often influences patient preference, particularly for busy UK professionals managing weight alongside demanding schedules.
Saxenda vs Wegovy Pricing: UK Treatment Costs
Understanding the financial commitment for Saxenda vs Wegovy treatment helps inform your decision. Wegovy starts at £79.99 for the 0.25mg starter dose, progressing through escalation phases: 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), reaching maintenance at 2.4mg (£209.99). New customers apply discount code FIRST40 at checkout, while returning patients use DOSE25 to access these prices.
Our bundle options provide treatment continuity — the Intro Trio (0.25mg, 0.5mg, 1mg) costs £299.99, covering your first 12 weeks of dose escalation. For maintenance therapy, the Ultimate Stability Trio provides three months of 2.4mg pens for £649.99, ensuring consistent supply without monthly reordering through our GPhC-registered pharmacy service.
Clinical Evidence Supporting Saxenda vs Wegovy Efficacy
The STEP programme provides robust evidence for Wegovy's effectiveness across diverse populations. STEP 3 combined Wegovy with intensive behavioural therapy, achieving approximately clinically studied weight loss, while STEP 5 demonstrated sustained results of 15.2% at two years. The SELECT cardiovascular outcomes trial showed additional benefits beyond weight management.
Saxenda's evidence base comes from the SCALE trials, demonstrating consistent weight loss maintenance when patients continued treatment alongside reduced-calorie diets and increased physical activity. Both treatments require ongoing commitment — discontinuation typically results in weight regain, emphasising that weight management represents a long-term healthcare strategy rather than short-term intervention.
How Wegovy Works vs Saxenda Mechanisms
Both Saxenda and Wegovy function as GLP-1 receptor agonists, mimicking natural fullness hormones that regulate appetite and satiety. Wegovy's semaglutide acts on brain appetite centres, potentially reducing food cravings and promoting feeling of fullness after smaller meals. The key difference lies in their molecular structure and duration of action — Wegovy's longer half-life enables weekly dosing, while Saxenda's liraglutide requires daily injection to maintain therapeutic levels. This mechanism helps patients feel satisfied with reduced calorie intake when combined with appropriate dietary modifications and physical activity programmes.
Ordering Process for Saxenda vs Wegovy Treatment
Accessing either treatment through EverydayMeds follows our streamlined clinical pathway designed for UK patients. Complete our 3-minute online assessment covering medical history, current medications, and weight management goals — no lengthy appointments or GP referrals required. Our prescribers review applications within 3 working days (express 24-hour service available), ensuring thorough clinical oversight for this prescription-only medicine. Once approved, next-day delivery arrives in temperature-controlled packaging, maintaining cold-chain integrity from our GPhC-registered facility (#9012878) to your door. Both Saxenda and Wegovy require proper clinical assessment before prescribing, reflecting their status as licensed medical treatments rather than lifestyle supplements.
Storage and Practical Considerations: Saxenda vs Wegovy
Storage requirements influence treatment practicality for many UK patients comparing Saxenda vs Wegovy options. Both require refrigeration at 2-8°C before first use, but Wegovy offers superior travel convenience with 6 weeks room temperature stability once removed from the fridge. Saxenda typically remains stable for shorter periods outside refrigeration, making Wegovy preferable for frequent travellers or those with unpredictable schedules. Both use pre-filled FlexTouch pen systems for easy self-administration, though Wegovy's weekly schedule reduces injection frequency compared to Saxenda's daily requirement. Dose escalation follows mandatory protocols to minimise side effects while optimising therapeutic outcomes.
UK Patient Success Patterns: Saxenda vs Wegovy Outcomes
Real-world UK prescribing patterns reveal interesting trends when comparing Saxenda vs Wegovy patient experiences. Many patients transitioning from daily to weekly injections report improved adherence and lifestyle integration with Wegovy's dosing schedule. Healthcare providers note that Wegovy's stronger clinical trial results often align with patient expectations, though individual responses vary significantly based on baseline characteristics and lifestyle factors.
Success with either treatment depends heavily on concurrent lifestyle modifications — patients combining injections with structured dietary changes and regular exercise typically achieve superior outcomes. Our clinical team provides ongoing support through the treatment journey, helping optimise results whether you choose Saxenda or Wegovy as your weight management tool alongside comprehensive lifestyle interventions.
Next Steps: Choosing Between Saxenda vs Wegovy
Ready to start your weight management journey with clinical evidence-based treatment? Our online assessment determines your suitability for either Saxenda or Wegovy based on your medical profile and treatment preferences. Apply discount code FIRST40 (new customers) or DOSE25 (returning patients) at checkout to access our competitive pricing structure. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment — our team provides expert guidance on selecting the most appropriate option for your circumstances. Remember that both treatments work best alongside reduced-calorie diets and increased physical activity, representing part of a comprehensive weight management strategy rather than standalone solutions. Start your consultation today and take the first step towards evidence-based weight management with professional clinical support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
